Dr John Ingram

Improving the care of people with hidradenitis suppurativa is Professor Ingram’s principal research and clinical focus within dermatology. Hidradenitis suppurativa (HS) is a painful chronic inflammatory skin disease, characterised by recurrent skin boils in flexural sites, producing a large impact on quality of life and affecting about 1% of the population globally.

Professor Ingram is a co-founder of HiSTORIC (https://www.c3outcomes.org/historic ) the core outcome domains global collaboration for HS and Chief Investigator of H-STRONG, the UK-Irish Treatment Registry Study. Previously he led several HS research consortia, including the Cochrane Review of Interventions for HS, James Lind Alliance HS Priority Setting Partnership, the British Association of Dermatologists HS Guideline Development Group, and the HTA-funded THESEUS study. He runs a HS multidisciplinary clinic in Cardiff and champions a holistic approach to HS care, integrating medical and surgical therapy.

Professor Ingram is also immediate past Editor-in-Chief of the British Journal of Dermatology (https://academic.oup.com/bjd ), ranked third of the 94 dermatology journals globally, leading the journal from 2019-2024.

In the news: 

Health and Care Research Wales invests in leaders across Wales to shape the research of the future (April 2022)